Natera Inc's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Depreciation" stands at 65.80 Million United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026, the highest value at least since 06/30/2014, the period currently displayed.
Natera Inc's second quarter result of 21.19 Million USD for the item "Depreciation" represents an increase of 4.76 percent compared to it's first quarter result.
Also, Natera Inc's second quarter result of 21.19 Million USD for the item "Depreciation" represents an increase of 114.91 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Natera Inc's second quarter result of 65.80 Million USD for the item "Depreciation" represents an increase of 20.80 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 87.54 percent compared to the value the year prior.
The 1 year change in percent is 87.54.
The 3 year change in percent is 241.44.
The 5 year change in percent is 568.79.
The 10 year change in percent is 1,218.94.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Depreciation | 905,699,262,464.00 |
![]() | Johnson & Johnson - Depreciation | 486,508,953,600.00 |
![]() | AbbVie Inc - Depreciation | 399,570,305,024.00 |
![]() | Roche Holding AG - Depreciation | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Depreciation | 280,205,508,085.11 |